Effect of Protein Supplementation After Bariatric Surgery
EPEAB
Impact of Protein Supplementation After Bariatric Surgery - a Randomized, Controlled, Double Blind Pilot Study
1 other identifier
interventional
35
1 country
1
Brief Summary
Obese patients, who underwent bariatric surgery, are at risk to develop protein malnutrition. The aim of this study is to evaluate the influence of postoperative protein supplementation on weight reduction, body composition and protein status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 20, 2013
CompletedFirst Posted
Study publicly available on registry
December 5, 2013
CompletedDecember 5, 2013
November 1, 2013
1.1 years
November 20, 2013
November 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Excess weight loss [%]
At month 6
Secondary Outcomes (1)
Content of lean body mass in lost weight [%]
At month 6
Other Outcomes (1)
Content of body fat in lost weight [%]
At month 6
Study Arms (2)
Protein group
EXPERIMENTALPatient group which takes daily protein supplements after bariatric surgery over 6 months. Protein product: Resource Instant Protein 88, Nestlé Health Nutrition
Control group
PLACEBO COMPARATORPatient group which takes daily isocaloric placebo after bariatric surgery over 6 months and thus can be compared to the protein group. Placebo product: Resource Maltodextrin, Nestlé Health Nutrition
Interventions
Protein product: Resource Instant Protein 88, Nestlé Health Nutrition; postoperative intake of 30 - 35 g powder per day over 6 months.
Placebo product (Resource Maltodextrin, Nestlé Health Nutrition). Postoperative intake of 30 - 35 g powder per day over 6 months.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- BMI of 35 kg/m2 or more
- Indication for laparoscopic sleeve gastrectomy or Roux-en Y gastric bypass
You may not qualify if:
- Renal disease
- Type 2 diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen
Tübingen, 72076, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan C Bischoff, Prof.Dr.med.
Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr. med. Stephan C. Bischoff
Study Record Dates
First Submitted
November 20, 2013
First Posted
December 5, 2013
Study Start
November 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
December 5, 2013
Record last verified: 2013-11